论文信息 - Report from Dagstuhl Seminar 13212 Computational Methods Aiding Early-Stage Drug Design

Report from Dagstuhl Seminar 13212 Computational Methods Aiding Early-Stage Drug Design

This report documents the program and the outcomes of Dagstuhl Seminar 13212 “Computational Methods Aiding Early-Stage Drug Design”. The aim of the seminar was to bring scientists working on various aspects of drug discovery, genomic technologies and computational science (e.g., bioinformatics, chemoinformatics, machine learning, and statistics) together to explore how high dimensional data sets created by genomic technologies can be integrated to identify functional manifestations of drug actions on living cells early in the drug discovery process. Seminar 19.–24. May, 2013 – www.dagstuhl.de/13212 1998 ACM Subject Classification G.3 Probability and Statistics, I.5 Pattern Recognition, J.2 Physical Sciences and Engineering, J.3 Life and Medical Sciences

S. Hochreiter | A. Bender | Z. Shkedy | H. Göhlmann

[1] Klaus Obermayer,et al. A new summarization method for affymetrix probe level data , 2006, Bioinform..

[2] Ulrich Bodenhofer,et al. FABIA: factor analysis for bicluster acquisition , 2010, Bioinform..

[3] Adetayo Kasim,et al. Filtering data from high-throughput experiments based on measurement reliability , 2010, Proceedings of the National Academy of Sciences.

[4] Ingrid G. Abfalter,et al. Complex Networks Govern Coiled-Coil Oligomerization – Predicting and Profiling by Means of a Machine Learning Approach , 2011, Molecular & Cellular Proteomics.